Carter Keller

Carter Keller Email and Phone Number

Chief Executive Officer at GigaGen Inc @ GigaGen Inc
About Carter Keller

Biotech entrepreneur with experience directing pharmaceutical development, marketing and product launches. I am interested in continuing to impact the state of healthcare by successfully developing and launching innovative drugs and ensuring that they reach the patients who need and value them.Co-founder and COO of GigaGen, a biotechnology start-up developing therapeutics for cancer, immune deficiency, and infectious disease.Co-founder of GigaMune, a cellular therapeutics company that is developing promising T cell receptor therapeutics directed against solid tumors. Previously held commercial leadership positions in public and private oncology and infectious disease focused biotechnology companies; Led successful US and European commercial launches of a new therapeutic into an orphan oncology indication; Developed and executed launch plans, commercial strategy, sales force sizing and targeting strategy, and revenue forecasts.Specialties: Fundraising, business development, corporate strategy, organizational planning, forecasting/valuation, marketing, market planning, management, pharmaceutical launch planning and execution, building and developing high performing teams

Carter Keller's Current Company Details
GigaGen Inc

Gigagen Inc

View
Chief Executive Officer at GigaGen Inc
Carter Keller Work Experience Details
  • Gigagen Inc
    Chief Executive Officer
    Gigagen Inc Oct 2021 - Present
    San Carlos, California, Us
  • Gigagen Inc
    Chief Operating Officer
    Gigagen Inc Dec 2014 - Oct 2021
    San Carlos, California, Us
    Managing operations, business development, marketing, finance and strategy for a biotechnology company that is revolutionizing the way therapeutics are discovered. Closed GigaGen's $50 million Series A financing in July 2017 to finance our drug development. More than $62M raised in grants, equity and partnership revenue.In March of 2021 GigaGen was acquired by Grifols, S.A., at a valuation of $142.9 million with the potential for further product-related payments.GigaGen is a clinical stage drug developer creating novel therapies for cancer, immune deficiency, and infectious disease. GigaGen has invented a technology that allows us to capture and identify every antibody in a human or animal in hours. We have the largest antibody library in the world and can identify antibody based drug candidates faster than any company in history. We have a pipeline of first-in-class biotherapeutics including novel oncology antibody drug combinations and the world’s first recombinant polyclonal hyperimmune gammaglobulin.
  • Gigamune
    Co-Founder
    Gigamune Jun 2017 - Present
    GigaMune is advancing T cell therapies for cancer by capturing and engineering T cell receptors (TCRs) directed against solid tumor targets.We use our industry-leading technology to capture TCR repertoires and internally discovered novel CRISPR-Cas enzymes for T cell genome engineering.
  • Exelixis
    Sr. Director, Marketing
    Exelixis Aug 2012 - Sep 2014
    Alameda, California, Us
    Responsible for launch planning and sales strategy for oncology programsLaunched Cometriq into medullary thyroid cancer in the US and the EU.Managed all ex-US marketing and sales management for Cometriq.Planned launch strategy for Cabometx in RCC and in prostate cancer.
  • Achaogen
    Director Strategic Marketing
    Achaogen Dec 2010 - Jul 2012
    South San Francisco, Ca, Us
    As head of the strategic marketing function at Achaogen I was responsible for managing communication, marketing, KOL relationships, market research, analysis/forecasting, drug development, competitive intelligence, and business development for a fast-paced, development-stage, pharmaceutical company. I created frameworks to assess corporate strategy and was a thought partner to executive management and the Board of Directors on commercial issues. Activities included delivering the commercial assessment for Achaogen's pipeline, identifying and analyzing new product opportunities, managing the publication plan, creating marketing collateral and conducting communication with key opinion leaders.
  • Genentech
    Group Manager, New Product Planning And Commercial Assessments
    Genentech Jul 2009 - Dec 2010
    South San Francisco, California, Us
    Led teams responsible for Genentech's oncology pipeline commercial strategy and for recommending cross portfolio strategies to the CEO and his executive team. Provided commercial rationale and valuations to BD for in-licensing and M&A opportunities, provided guidance for currently marketed therapies and pipeline products and led cross-portfolio initiatives - developing US strategies for REMS, Bio-generics, devices and diagnostics.Provided oncology pipeline valuation and rationale to support negotiations during Roche acquisition. Served as commercial operations lead on integration team post Roche acquisition.
  • Genentech
    Principal
    Genentech Nov 2008 - Jul 2009
    South San Francisco, California, Us
  • Genentech
    Sr Market Planning Manager
    Genentech Sep 2006 - Nov 2008
    South San Francisco, California, Us
  • Genentech
    Market Planning Manager
    Genentech Jul 2004 - Jul 2006
    South San Francisco, California, Us
  • Burrill & Company
    Associate Intern
    Burrill & Company Jun 2003 - Jan 2004
  • Ingenio
    Business Development Manager
    Ingenio Mar 2000 - Nov 2001
    Negotiation
  • Apm
    Junior Associate
    Apm 1997 - 2000

Carter Keller Skills

Strategy Biotechnology Market Research Oncology Pharmaceutical Industry Business Strategy Product Development Competitive Intelligence Business Development Cross Functional Team Leadership Marketing Strategy Lifesciences Marketing Market Planning Product Launch Due Diligence Life Sciences Market Analysis Start Ups Strategic Planning Commercial Assessment Medical Devices Drug Development Forecasting Corporate Development Commercialization Clinical Development Management Infectious Diseases Deal Sourcing Mergers And Acquisitions Biopharmaceuticals Competitive Analysis Leadership

Carter Keller Education Details

  • University Of California, Berkeley, Haas School Of Business
    University Of California, Berkeley, Haas School Of Business
    Biotechnology
  • Stanford University
    Stanford University
    Premed
  • Phillips Academy Andover
    Phillips Academy Andover
    High School Diploma

Frequently Asked Questions about Carter Keller

What company does Carter Keller work for?

Carter Keller works for Gigagen Inc

What is Carter Keller's role at the current company?

Carter Keller's current role is Chief Executive Officer at GigaGen Inc.

What is Carter Keller's email address?

Carter Keller's email address is c.****@****ail.com

What is Carter Keller's direct phone number?

Carter Keller's direct phone number is +180589*****

What schools did Carter Keller attend?

Carter Keller attended University Of California, Berkeley, Haas School Of Business, Stanford University, Phillips Academy Andover.

What are some of Carter Keller's interests?

Carter Keller has interest in Kids, Cooking, Electronics, Traveling, Home Improvement, Reading, Travel, Home Decoration.

What skills is Carter Keller known for?

Carter Keller has skills like Strategy, Biotechnology, Market Research, Oncology, Pharmaceutical Industry, Business Strategy, Product Development, Competitive Intelligence, Business Development, Cross Functional Team Leadership, Marketing Strategy, Lifesciences.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.